{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:00:29Z","timestamp":1776873629738,"version":"3.51.2"},"reference-count":60,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":1426,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK101240"],"award-info":[{"award-number":["DK101240"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F31HL132419"],"award-info":[{"award-number":["F31HL132419"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["Postdoctoral Fellowship"],"award-info":[{"award-number":["Postdoctoral Fellowship"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1074\/jbc.m116.732743","type":"journal-article","created":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T02:09:23Z","timestamp":1473473363000},"page":"23188-23198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin"],"prefix":"10.1016","volume":"291","author":[{"given":"Andrew M.","family":"Shearer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajashree","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyn","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Baleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nga","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidija","family":"Covic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athan","family":"Kuliopulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.732743_bib1","series-title":"World Gastroenterology Organisation Global Guidelines (World Gastroenterology Organisation, ed)","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","author":"LaBrecque","year":"2012"},{"key":"10.1074\/jbc.M116.732743_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00535-012-0527-x","article-title":"Inflammation and fibrogenesis in steatohepatitis","volume":"47","author":"Fujii","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1074\/jbc.M116.732743_bib3","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1074\/jbc.M116.732743_bib4","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Investig"},{"key":"10.1074\/jbc.M116.732743_bib5","article-title":"Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors","author":"Wieser","year":"2016","journal-title":"Gut"},{"key":"10.1074\/jbc.M116.732743_bib6","first-page":"1011","article-title":"Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases","volume":"30","author":"Novo","year":"2015","journal-title":"Histol. Histopathol"},{"key":"10.1074\/jbc.M116.732743_bib7","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M116.732743_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13105-011-0101-7","article-title":"Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes","volume":"67","author":"Sauvant","year":"2011","journal-title":"J. Physiol. Biochem"},{"key":"10.1074\/jbc.M116.732743_bib9","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.M116.732743_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.21254","article-title":"Mechanisms of endotoxin-induced NO, IL-6, and TNF-\u03b1 production in activated rat hepatic stellate cells: role of p38 MAPK","volume":"44","author":"Thirunavukkarasu","year":"2006","journal-title":"Hepatology"},{"key":"10.1074\/jbc.M116.732743_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/jbc.M116.732743_bib12","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.732743_bib13","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.1017091108","article-title":"Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins","volume":"108","author":"Sevigny","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.732743_bib14","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1161\/ATVBAHA.111.238261","article-title":"Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia","volume":"31","author":"Sevigny","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.M116.732743_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.24784","article-title":"Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells","volume":"55","author":"Knight","year":"2012","journal-title":"Hepatology"},{"key":"10.1074\/jbc.M116.732743_bib16","doi-asserted-by":"crossref","first-page":"37319","DOI":"10.1074\/jbc.M113.492793","article-title":"Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-\u03b2 receptor signaling pathways contributes to renal fibrosis","volume":"288","author":"Chung","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.732743_bib17","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2353\/ajpath.2010.091107","article-title":"Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis","volume":"177","author":"Borensztajn","year":"2010","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.M116.732743_bib18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.chembiol.2003.10.014","article-title":"Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding","volume":"10","author":"Seeley","year":"2003","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.M116.732743_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cell.2009.02.018","article-title":"Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site","volume":"137","author":"Trivedi","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.732743_bib20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/bph.12544","article-title":"Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease","volume":"171","author":"Hollenberg","year":"2014","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.M116.732743_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.ATV.0000258862.61067.14","article-title":"Membrane-type serine protease-1\/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis","volume":"27","author":"Seitz","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.M116.732743_bib22","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1073\/pnas.97.10.5255","article-title":"Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa","volume":"97","author":"Camerer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.732743_bib23","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.141126698","article-title":"Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor","volume":"98","author":"Riewald","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.732743_bib24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm.2461","article-title":"Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation","volume":"17","author":"Badeanlou","year":"2011","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M116.732743_bib25","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2012-09-455436","article-title":"Hepatocyte tissue factor activates the coagulation cascade in mice","volume":"121","author":"Sullivan","year":"2013","journal-title":"Blood"},{"key":"10.1074\/jbc.M116.732743_bib26","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/hep.27033","article-title":"Circulating microparticle tissue factor activity is increased in patients with cirrhosis","volume":"60","author":"Rautou","year":"2014","journal-title":"Hepatology"},{"key":"10.1074\/jbc.M116.732743_bib27","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.271.25.14910","article-title":"The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor","volume":"271","author":"Nystedt","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.732743_bib28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1164\/rccm.201009-1479OC","article-title":"Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis","volume":"183","author":"Wygrecka","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1074\/jbc.M116.732743_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.lfs.2003.09.012","article-title":"Blocking receptors on the inside: pepducin-based intervention of PAR signaling and thrombosis","volume":"74","author":"Kuliopulos","year":"2003","journal-title":"Life Sci"},{"key":"10.1074\/jbc.M116.732743_bib30","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1074\/jbc.R112.355461","article-title":"Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development","volume":"287","author":"O'Callaghan","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.732743_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/ATVBAHA.115.306777","article-title":"Cell-penetrating pepducin therapy targeting PAR1 in subjects with coronary artery disease","volume":"36","author":"Gurbel","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.M116.732743_bib32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1073\/pnas.022460899","article-title":"Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides","volume":"99","author":"Covic","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.732743_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1538-7836.2007.02364.x","article-title":"Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists","volume":"5","author":"Wielders","year":"2007","journal-title":"J. Thromb. Haemost"},{"key":"10.1074\/jbc.M116.732743_bib34","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1039\/c3ob27445d","article-title":"FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes","volume":"11","author":"Tsuji","year":"2013","journal-title":"Org. Biomol. Chem"},{"key":"10.1074\/jbc.M116.732743_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.112.091918","article-title":"Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin","volume":"126","author":"Zhang","year":"2012","journal-title":"Circulation"},{"key":"10.1074\/jbc.M116.732743_bib36","doi-asserted-by":"crossref","first-page":"15785","DOI":"10.1074\/jbc.M115.636316","article-title":"Allosteric activation of a G protein-coupled receptor with cell-penetrating receptor mimetics","volume":"290","author":"Zhang","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.732743_bib37","doi-asserted-by":"crossref","first-page":"E5088","DOI":"10.1073\/pnas.1312515110","article-title":"Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein","volume":"110","author":"Quoyer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.732743_bib38","doi-asserted-by":"crossref","first-page":"G516","DOI":"10.1152\/ajpgi.00296.2012","article-title":"Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis","volume":"304","author":"Michael","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"10.1074\/jbc.M116.732743_bib39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ar.22694","article-title":"Codistribution of collagen type IV and laminin in liver fibrosis of elderly cadavers: immunohistochemical marker of perisinusoidal basement membrane formation","volume":"296","author":"Mak","year":"2013","journal-title":"Anat. Rec"},{"key":"10.1074\/jbc.M116.732743_bib40","first-page":"423","article-title":"Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration","volume":"152","author":"Marra","year":"1998","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.M116.732743_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","article-title":"Crystal structure of the \u03b22 adrenergic receptor-Gs protein complex","volume":"477","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.732743_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1582-4934.2009.00980.x","article-title":"The coagulation factor Xa\/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm","volume":"14","author":"Borensztajn","year":"2010","journal-title":"J. Cell. Mol. Med"},{"key":"10.1074\/jbc.M116.732743_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5482\/HAMO-14-11-0068","article-title":"Tissue factor pathways linking obesity and inflammation","volume":"35","author":"Ruf","year":"2015","journal-title":"Hamostaseologie"},{"key":"10.1074\/jbc.M116.732743_bib44","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cdd.2016.8","article-title":"Cancer therapy in the necroptosis era","volume":"23","author":"Su","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1074\/jbc.M116.732743_bib45","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"10.1074\/jbc.M116.732743_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M116.732743_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection","volume":"73","author":"Pfeffer","year":"1993","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.732743_bib48","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.732743_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.immuni.2008.10.017","article-title":"Fatal hepatitis mediated by tumor necrosis factor TNF\u03b1 requires caspase-8 and involves the BH3-only proteins Bid and Bim","volume":"30","author":"Kaufmann","year":"2009","journal-title":"Immunity"},{"key":"10.1074\/jbc.M116.732743_bib50","first-page":"2380","article-title":"Smoothened is a master regulator of adult liver repair","volume":"123","author":"Michelotti","year":"2013","journal-title":"J. Clin. Investig"},{"key":"10.1074\/jbc.M116.732743_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.732743_bib52","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","article-title":"Mechanisms of liver injury. I. TNF-\u03b1-induced liver injury: role of IKK, JNK, and ROS pathways","volume":"290","author":"Schwabe","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"10.1074\/jbc.M116.732743_bib53","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1074\/jbc.275.1.705","article-title":"Hepatocytes sensitized to tumor necrosis factor-\u03b1 cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways","volume":"275","author":"Jones","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.732743_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/gut.47.2.309","article-title":"Interleukin 6 and liver regeneration","volume":"47","author":"Streetz","year":"2000","journal-title":"Gut"},{"key":"10.1074\/jbc.M116.732743_bib55","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1038\/sj.onc.1203707","article-title":"Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells","volume":"19","author":"Klausen","year":"2000","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M116.732743_bib56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.21087","article-title":"Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair","volume":"43","author":"Jin","year":"2006","journal-title":"Hepatology"},{"key":"10.1074\/jbc.M116.732743_bib57","doi-asserted-by":"crossref","first-page":"17753","DOI":"10.1074\/jbc.C800040200","article-title":"Crystal structure of squid rhodopsin with intracellularly extended cytoplasmic region","volume":"283","author":"Shimamura","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.732743_bib58","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jmb.2011.08.044","article-title":"Crystallographic analysis of the primary photochemical reaction of squid rhodopsin","volume":"413","author":"Murakami","year":"2011","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.M116.732743_bib59","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ni1525","article-title":"'Role reversal\u2019 for the receptor PAR1 in sepsis-induced vascular damage","volume":"8","author":"Kaneider","year":"2007","journal-title":"Nat. Immunol"},{"key":"10.1074\/jbc.M116.732743_bib60","doi-asserted-by":"crossref","first-page":"21364","DOI":"10.1016\/S0021-9258(17)31971-3","article-title":"Localization of the affinity peptide-substrate inactivator site on recombinant vitamin K-dependent carboxylase","volume":"269","author":"Kuliopulos","year":"1994","journal-title":"J. Biol. Chem"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820356891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820356891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.732743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T01:05:48Z","timestamp":1639703148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820356891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":60,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0021925820356891"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.732743","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.732743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}